Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
Public ClinicalTrials.gov record NCT03016741. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Cognitive Effects of Androgen Receptor (AR) Directed Therapies for Advanced Prostate Cancer
Study identification
- NCT ID
- NCT03016741
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Northwestern University
- Other
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
- Abiraterone Acetate Drug
- Enzalutamide Drug
- GnRH agonist/antagonist Biological
- Prednisone Drug
Drug · Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 30, 2017
- Primary completion
- Jan 3, 2023
- Completion
- Jul 31, 2029
- Last update posted
- Feb 23, 2026
2017 – 2029
United States locations
- U.S. sites
- 5
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope Comprehensive Cancer Center | Los Angeles | California | 91010 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Tulane Cancer Center | New Orleans | Louisiana | 70112 | — |
| University of Minnesota: Masonic Cancer Center | Minneapolis | Minnesota | 55455 | — |
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37232 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03016741, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 23, 2026 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03016741 live on ClinicalTrials.gov.